Download this presentation now to find out more about:
- ViscoGel® – a viscoelastic hydrogel based on chitosan
- Unique advantages of ViscoGel as adjuvant
- Model vaccine for Proof-of-concept studies of ViscoGel as adjuvant
- Pre-clinical evaluation: ViscoGel enhances the antibody response to Act-HIB
- ViscoGel enhances the cellular response and promotes a mixed cytokine profile in response to Act-HIB
…And much more!
If you are interested in finding out more about vaccine supply, then join us at the 15th Annual World Vaccine Congress Europe.